このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Pediatric OCD Talus RCT Feasibility

2026年11月16日 更新者:Magdalena Tarchala、Children's Hospital of Eastern Ontario

Feasibility of a Randomized Trial Comparing Viable Cartilage Allograft and Arthroscopic Drilling for Pediatric Talar Osteochondritis Dissecans

Osteochondritis dissecans (OCD) of the talus is a condition affecting the bone and cartilage of the ankle joint. It can cause pain, swelling, stiffness, and difficulty participating in sports and daily activities. Children and adolescents with persistent symptoms or unstable lesions may require surgery when nonsurgical treatments are unsuccessful.

Two surgical approaches used to treat this condition are arthroscopic drilling and chondroplasty, which aim to stimulate healing of the affected bone and cartilage, and viable cartilage allograft implantation, which uses donated cartilage material to repair the damaged area. There is limited evidence comparing these treatments in children and adolescents, and it is not known whether one approach provides better outcomes.

This pilot randomized controlled trial aims to assess the feasibility of conducting a larger study comparing these two surgical treatments in pediatric patients with talar OCD. Approximately 20 participants requiring surgery will be recruited at the Children's Hospital of Eastern Ontario (CHEO) and randomly assigned to receive either viable cartilage allograft implantation (CartiMax®) or arthroscopic drilling and chondroplasty.

The primary objective is to assess the feasibility of recruitment, acceptance of randomization, participant retention, completion of imaging and questionnaires, and adherence to the study procedures. Secondary objectives include exploring differences in ankle pain, function, healing on magnetic resonance imaging (MRI), complications, and the need for additional surgery.

Participants will undergo postoperative rehabilitation according to standard clinical care and will be followed for up to 24 months after surgery.

The findings will help determine whether a larger multicentre randomized trial is feasible and provide preliminary information about healing and recovery following each surgical treatment. This pilot study is not designed to determine which treatment is more effective.

調査の概要

詳細な説明

Osteochondritis dissecans (OCD) of the talus is a condition that affects the bone and cartilage in the ankle joint. It can cause pain, swelling, stiffness, and difficulty participating in sports and everyday activities. Some children and adolescents with this condition require surgery when treatments such as rest, activity restrictions, and immobilization have not improved their symptoms.

Two surgical approaches are available to treat this condition. One involves drilling small holes into the affected bone and smoothing damaged cartilage to encourage healing. The other involves placing donated cartilage material into the damaged area to support cartilage repair. It is not yet known whether one approach leads to better healing and recovery in children and adolescents.

The main purpose of this pilot study is to determine whether it is feasible to conduct a larger study comparing these two surgical treatments. Researchers will assess whether enough patients can be recruited, whether families are willing to accept random assignment to either treatment, and whether participants can complete the required follow-up visits, imaging, and questionnaires.

The study will include approximately 20 children and adolescents who require surgery for osteochondritis dissecans of the talus at the Children's Hospital of Eastern Ontario (CHEO) in Ottawa, Canada. Participants will be randomly assigned, like flipping a coin, to receive one of two surgical treatments:

  • **Viable cartilage allograft:** Surgery to prepare the damaged area and place donated cartilage material (CartiMax®) into the defect.
  • **Arthroscopic drilling and chondroplasty:** Surgery using a small camera and instruments to smooth damaged cartilage and drill into the underlying bone to encourage healing.

All participants will receive the same standard postoperative rehabilitation approach. Follow-up assessments will take place approximately 2 weeks, 6 weeks, 3 months, 6 months, 12 months, and 24 months after surgery. Researchers will assess ankle pain, function, healing on imaging, return to sports, complications, and whether additional surgery is needed.

The researchers expect this pilot study to help determine whether a larger randomized trial can be successfully conducted. The study will also provide early information about healing and recovery after each treatment. Because this is a small pilot study, it is not designed to determine which surgical treatment is better.

研究の種類

介入

入学 (推定)

20

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

  • 名前:Holly Livock Research Manager, MSc.
  • 電話番号:4120 6137377600
  • メール:hlivock@cheo.on.ca

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

5年~18年 (子、大人)

健康ボランティアの受け入れ

いいえ

受講資格のある性別

全て

説明

Inclusion Criteria:

  • Patients aged ≤ 5 years and ≥ 18 years
  • Patients seen at the CHEO Orthopaedic Sports Medicine Clinic with symptomatic talar OCD requiring surgery
  • Patients that have an unstable lesion on MRI
  • Must be able to complete patient-reported outcome measures in English or French
  • Are willing to be randomized between the two unblinded surgical approaches.
  • Participants must have had failure of non-operative treatment including rest, activity restriction, and six weeks of immobilization.

Exclusion Criteria:

  • Unwillingness to attend follow-up appointments or complete research activities.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:処理
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
実験的:Viable Cartilage Allograft (CartiMax)

Participants undergo arthroscopic lesion preparation followed by implantation of CartiMax viable cartilage allograft into the damaged area of the talus. Standard postoperative rehabilitation is provided.

Participants undergo arthroscopic preparation of the talar osteochondral lesion followed by implantation of CartiMax viable cartilage allograft, consisting of viable cartilage fibers and cartilage allograft matrix. The graft is placed into the cartilage defect to support repair. Participants follow the standard postoperative rehabilitation protocol.

アクティブコンパレータ:Arthroscopic Drilling and Chondroplasty

Participants undergo arthroscopic drilling and chondroplasty to remove or smooth unstable cartilage and stimulate healing of the underlying bone. Standard postoperative rehabilitation is provided.

Participants undergo arthroscopic drilling and chondroplasty of the talar osteochondral lesion. Unstable cartilage is removed or smoothed, and small channels are drilled into the affected bone to stimulate healing. Participants follow the standard postoperative rehabilitation protocol.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Recruitment Rate
時間枠:24 months

Number of participants enrolled per year during the recruitment period. Recruitment feasibility will be assessed against a target of at least 10 participants enrolled per year.

24 months

二次結果の測定

結果測定
メジャーの説明
時間枠
Questionnaire Completion Rate at 6 Months
時間枠:6 months after surgery

Proportion of randomized participants who complete the required 6-month postoperative pain and ankle function assessments, including the Visual Analogue Scale (VAS) and American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot score. The target questionnaire completion rate is at least 80%.

6 months after surgery
MRI Completion Rate at 6 Months
時間枠:6 months after surgery

Proportion of randomized participants who complete the scheduled 6-month postoperative magnetic resonance imaging (MRI) assessment. The target MRI completion rate is at least 80%.

6 months after surgery
Participant Retention Rate at 6 Months
時間枠:24 months

Proportion of randomized participants who remain in the study and complete the 6-month postoperative follow-up assessment. The target retention rate is at least 70%.

24 months
Randomization Acceptance Rate
時間枠:24 months

Proportion of eligible patients approached for participation who consent to random assignment to either surgical treatment. The target randomization acceptance rate is at least 80%.

24 months
Adherence to Randomized Treatment Allocation
時間枠:At the time of surgery (assessed up to 1 hour)

Proportion of randomized participants who undergo their assigned surgical intervention, either viable cartilage allograft implantation or arthroscopic drilling and chondroplasty. Crossovers and deviations from assigned treatment will be documented.

At the time of surgery (assessed up to 1 hour)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

一般刊行物

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2027年1月1日

一次修了 (推定)

2029年1月1日

研究の完了 (推定)

2030年1月1日

試験登録日

最初に提出

2026年11月10日

QC基準を満たした最初の提出物

2026年11月16日

最初の投稿 (実際)

2026年11月18日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月18日

QC基準を満たした最後の更新が送信されました

2026年11月16日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • 26/10E

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する